Opportunity Radar

← Back to search

Contract

SAFE-PLASMA Protocol

View on SAM.gov ↗ Sign in to save

Type
Contract
Notice type
Special Notice
Agency
DEPT OF DEFENSE
Sub-agency
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY (DHA)
Solicitation #
HT9427-27-NOI-701
Posted
Nov 17, 2026
Response due
Nov 23, 2026
Archive date
Dec 8, 2026
NAICS
541715
Place of performance
Frederick, SD, USA
Contact
Jamie Diggs · jamie.l.diggs.civ@health.mil
Source
SAM.gov

Description

The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval.

Similar open opportunities

ContractAward Notice

Sumatriptan Succinate Tablets

DEPT OF DEFENSE · DEFENSE LOGISTICS AGENCY

Due
—
Posted
Aug 24, 2023
NAICS
325412
Place
Carole Park, AU-ACT
Amount
$14,927,157